3-V Biosciences, Inc.
Records under this name other than the patents 3-V Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,624,173 | Heterocyclic Modulators of Lipid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 9,809,591 | Heterocyclic Modulators of Lipid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 11,034,690 | Heterocyclic Modulators of Lipid Synthesis Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,871,790 | Heterocyclic Modulators of Lipid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 10,226,449 | Heterocyclic Modulators of Lipid Synthesis and Combinations Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,622,968 | Heterocyclic Modulators of Lipid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 9,994,550 | Heterocyclic Modulators of Lipid Synthesis for Use Against Cancer and Viral Infections Formerly held In force · High confidence | In force | High confidence | |
| US 10,363,249 | Fatty Acid Synthase Inhibitor for Use in the Treatment of Drug Resistant Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,189,822 | Heterocyclic Modulators of Lipid Synthesis Formerly held In force · High confidence | In force | High confidence | |
| US 7,220,769 | Azolylbenzamides and analogues and their use for treating osteoporosis Lapsed on the fee record Ended May 22, 2015 · USPTO record | Lapsed on the fee record | Ended May 22, 2015 | USPTO record |